Full Text of HB5527 98th General Assembly
HB5527 98TH GENERAL ASSEMBLY |
| | 98TH GENERAL ASSEMBLY
State of Illinois
2013 and 2014 HB5527 Introduced , by Rep. Dennis M. Reboletti - John D. Anthony - John M. Cabello SYNOPSIS AS INTRODUCED: |
|
720 ILCS 570/406 | from Ch. 56 1/2, par. 1406 |
|
Amends the Illinois Controlled Substances Act. Provides various penalties for knowingly withholding information from a practitioner from whom a person seeks to obtain a controlled substance or a prescription for a controlled substance. Provides that a health care practitioner with the intent to provide a controlled substance or combination of controlled substances that are not medically necessary to his or her patient or an amount of controlled substances that is not medically necessary for his or her patient, may not provide a controlled substance or a prescription for a controlled substance by misrepresentation, fraud, forgery, deception, subterfuge, or concealment of a material fact. Provides that a violation is a Class 4 felony for the first offense and a Class 3 felony for each subsequent offense.
The fine for the first offense shall be not more than $100,000. The fine
for each subsequent offense shall not be more than $200,000.
|
| |
| | | CORRECTIONAL BUDGET AND IMPACT NOTE ACT MAY APPLY | |
| | A BILL FOR |
|
| | | HB5527 | | LRB098 16258 RLC 51317 b |
|
| 1 | | AN ACT concerning criminal law.
| 2 | | Be it enacted by the People of the State of Illinois,
| 3 | | represented in the General Assembly:
| 4 | | Section 5. The Illinois Controlled Substances Act is | 5 | | amended by changing Section 406 as follows:
| 6 | | (720 ILCS 570/406) (from Ch. 56 1/2, par. 1406)
| 7 | | Sec. 406. (a) It is unlawful for any person:
| 8 | | (1) who is subject to Article III knowingly to | 9 | | distribute or dispense
a controlled substance in violation | 10 | | of Sections 308 through 314.5 of this Act; or
| 11 | | (2) who is a registrant, to manufacture a controlled | 12 | | substance not
authorized by his or her registration, or to | 13 | | distribute or dispense a controlled
substance not | 14 | | authorized by his or her registration to another registrant | 15 | | or other
authorized person; or
| 16 | | (3) to refuse or fail to make, keep or furnish any | 17 | | record, notification,
order form, statement, invoice or | 18 | | information required under this Act; or
| 19 | | (4) to refuse an entry into any premises for any | 20 | | inspection authorized by
this Act; or
| 21 | | (5) knowingly to keep or maintain any store, shop, | 22 | | warehouse, dwelling,
building, vehicle, boat, aircraft, or | 23 | | other structure or place, which is
resorted to by a person |
| | | HB5527 | - 2 - | LRB098 16258 RLC 51317 b |
|
| 1 | | unlawfully possessing controlled substances, or
which is | 2 | | used for possessing, manufacturing, dispensing or | 3 | | distributing
controlled substances in violation of this | 4 | | Act.
| 5 | | Any person who violates this subsection (a) is guilty of a | 6 | | Class A
misdemeanor for the first offense and a Class 4 felony | 7 | | for each subsequent
offense. The fine for each subsequent | 8 | | offense shall not be more than
$100,000. In addition, any | 9 | | practitioner who is found guilty of violating
this subsection | 10 | | (a) is subject to suspension and revocation of his or her
| 11 | | professional license, in accordance with such procedures as are | 12 | | provided by
law for the taking of disciplinary action with | 13 | | regard to the license of
said practitioner's profession.
| 14 | | (b) It is unlawful for any person knowingly:
| 15 | | (1) to distribute, as a registrant, a controlled | 16 | | substance classified
in Schedule I or II, except pursuant | 17 | | to an order form as required by Section
307 of this Act; or
| 18 | | (2) to use, in the course of the manufacture or | 19 | | distribution of a
controlled
substance, a registration | 20 | | number which is fictitious, revoked, suspended,
or issued | 21 | | to another person; or
| 22 | | (3) to acquire or obtain possession of a controlled | 23 | | substance by
misrepresentation, fraud, forgery, deception | 24 | | or subterfuge; or
| 25 | | (3.1) to withhold information from a practitioner from | 26 | | whom the person seeks to obtain a controlled substance or a |
| | | HB5527 | - 3 - | LRB098 16258 RLC 51317 b |
|
| 1 | | prescription for a controlled substance that the person | 2 | | making the request has received a controlled substance or a | 3 | | prescription for a controlled substance of like | 4 | | therapeutic use from another practitioner within the | 5 | | previous 30 days; or | 6 | | (3.2) with the intent to obtain a controlled substance | 7 | | or combination of controlled substances that are not | 8 | | medically necessary for the person or an amount of a | 9 | | controlled substance or substances that is not medically | 10 | | necessary for the person, obtain or attempt to obtain from | 11 | | a practitioner a controlled substance or a prescription for | 12 | | a controlled substance by misrepresentation, fraud, | 13 | | forgery, deception, subterfuge, or concealment of a | 14 | | material fact. For purposes of this paragraph (3.2), a | 15 | | material fact includes whether the person has an existing | 16 | | prescription for a controlled substance issued for the same | 17 | | period of time by another practitioner or as described in | 18 | | paragraph (3.1) of this subsection (b); or
| 19 | | (4) to furnish false or fraudulent material | 20 | | information in, or omit any
material information from, any | 21 | | application, report or other document required
to be kept | 22 | | or filed under this Act, or any record required to be kept | 23 | | by
this Act; or
| 24 | | (5) to make, distribute or possess any punch, die, | 25 | | plate, stone or other
thing designed to print, imprint or | 26 | | reproduce the trademark, trade name
or other identifying |
| | | HB5527 | - 4 - | LRB098 16258 RLC 51317 b |
|
| 1 | | mark, imprint or device of another, or any likeness
of any | 2 | | of the foregoing, upon any controlled substance or | 3 | | container or labeling
thereof so as to render the drug a | 4 | | counterfeit substance; or
| 5 | | (6) (blank); or
| 6 | | (7) (blank).
| 7 | | Any person who violates this subsection (b) is guilty of a | 8 | | Class 4 felony
for the first offense and a Class 3 felony for | 9 | | each subsequent offense.
The fine for the first offense shall | 10 | | be not more than $100,000. The fine
for each subsequent offense | 11 | | shall not be more than $200,000.
| 12 | | (b-5) A health care practitioner with the intent to provide | 13 | | a controlled substance or combination of controlled substances | 14 | | that are not medically necessary to his or her patient or an | 15 | | amount of controlled substances that is not medically necessary | 16 | | for his or her patient, may not provide a controlled substance | 17 | | or a prescription for a controlled substance by | 18 | | misrepresentation, fraud, forgery, deception, subterfuge, or | 19 | | concealment of a material fact. For purposes of this subsection | 20 | | (b-5), a material fact includes whether the patient has an | 21 | | existing prescription for a controlled substance issued for the | 22 | | same period of time by another practitioner or as described in | 23 | | paragraph (3.1) of subsection (b). | 24 | | Any person or practitioner who violates the provisions of | 25 | | this subsection (b-5) is guilty of a Class 4 felony for the | 26 | | first offense and a Class 3 felony for each subsequent offense.
|
| | | HB5527 | - 5 - | LRB098 16258 RLC 51317 b |
|
| 1 | | The fine for the first offense shall be not more than $100,000. | 2 | | The fine
for each subsequent offense shall not be more than | 3 | | $200,000. | 4 | | (c) A person who knowingly or intentionally violates | 5 | | Section 316, 317, 318,
or 319 is guilty of a Class A | 6 | | misdemeanor.
| 7 | | (Source: P.A. 97-334, eff. 1-1-12.)
|
|